WT1 and neoplasm: When CCR2 was transduced together with a TCR specific for WT1 into CD3+ human T cells, double gene-modified CD3+ T cells demonstrated CCL2-tropic tumor trafficking and potentiated antitumor activity against WT1-expressing LK79 lung cancer cells both in vitro and in vivo (168).